NCT00902512

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Relative Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations In Healthy Volunteers Under Fasting Conditions.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: Male
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

the pharmacokinetics of sildenafil following single doses of sildenafil CT administered with and without water is similar relative to the conventional oral tablet of sildenafil administered with water.

Conditions

• Healthy Males

Interventions

Type	Name	Description
DRUG	Treatment A	Viagra® 100 mg tablet, administered with water single dose
DRUG	Blood samples for the analysis of sildenafil in plasma	Blood samples for the analysis of sildenafil in plasma
DRUG	Treatment B	Sildenafil 100 mg CT administered with water single dose
OTHER	Blood samples for the analysis of sildenafil in plasma	Blood samples for the analysis of sildenafil in plasma
DRUG	Treatment C	Sildenafil 100 mg CT administered without water single dose
OTHER	Blood samples for the analysis of sildenafil in plasma	Blood samples for the analysis of sildenafil in plasma

Timeline

• Start date: 2009-04-01
• Primary completion: 2009-04-01
• Completion: 2009-04-01
• First posted: 2009-05-15
• Last updated: 2021-02-01

Locations

1 site across 1 country: Mexico